MindMed Expands its Drug Development Pipeline with Launch of R(-)-MDMA Program

Mind Medicine Inc. is pleased to announce an expansion of its pipeline with the launch of a program to develop R(-)-MDMA for the treatment of social anxiety and functioning in diagnoses that include Autism Spectrum Disorder.

Category Press Release
?>